| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 12/11/2002 | EP1263719A1 N-deacetylthiocolchine derivatives and pharmaceutical compositions containing them |
| 12/11/2002 | EP1263718A1 Novel use of phenylheteroalkylamine derivatives |
| 12/11/2002 | EP1263715A1 Novel phenylheteroalkylamine derivatives |
| 12/11/2002 | EP1263714A1 Novel phenylheteroalkylamine derivatives |
| 12/11/2002 | EP1263711A1 Novel use of phenylheteroalkylamine derivatives |
| 12/11/2002 | EP1263504A2 Compounds with 5-ht1a activity useful for treating disorders of the outer retina |
| 12/11/2002 | EP1263470A1 METHOD FOR PRODUCING A COENZYME Q10 / $g(g)-CYCLODEXTRIN COMPLEX |
| 12/11/2002 | EP1263467A1 Improved paste formulations |
| 12/11/2002 | EP1263465A2 Photodynamic cellular and acellular organism eradication using a photosensitive material and surfactant |
| 12/11/2002 | EP1263464A1 Use of tgf-beta antagonists to treat or to prevent loss of renal function |
| 12/11/2002 | EP1263463A1 Use of a compound that selectively binds to cd123 to impair hematologic cancer progenitor cells |
| 12/11/2002 | EP1263461A1 Adenovirus formulations |
| 12/11/2002 | EP1263459A2 Attenuation of fibroblast proliferation |
| 12/11/2002 | EP1263457A2 Hiv immune adjuvant therapy |
| 12/11/2002 | EP1263456A2 A method for reversing the immunosuppressive effects of the melanoma inhibitory activity "mia" |
| 12/11/2002 | EP1263454A2 Methods for enhancing the bioavailability of a drug |
| 12/11/2002 | EP1263452A2 Methods and compositions for generating angiostatin |
| 12/11/2002 | EP1263446A2 Mixture comprising an inhibitor or suppressor of a gene and a molecule binding to an expression product of that gene |
| 12/11/2002 | EP1263443A1 Metalloproteinase inhibitors for the treatment of respiratoty diseases |
| 12/11/2002 | EP1263435A1 Pharmaceutical composition for treatment and prevention of liver fibrosis and cirrhosis |
| 12/11/2002 | EP1263434A1 Compounds with 5-ht 2 and 5-ht 1a agonist activity for treating glaucoma |
| 12/11/2002 | EP1263433A2 Glycogen phosphorylase inhibitor |
| 12/11/2002 | EP1263430A2 Treatment of diseases associated with cytokine production with inhibitors of the tec family of protein tyrosine kinases |
| 12/11/2002 | EP1263424A2 Use of deramciclane for the treatment of anxiety and depression |
| 12/11/2002 | EP1263421A2 Dual inhibitors of cholesteryl ester and wax ester synthesis for sebaceous gland disorders |
| 12/11/2002 | EP1263419A2 Compounds capable of binding with the cytoskeleton |
| 12/11/2002 | EP1263414A1 Pharmaceutical compositions of glycogen phosphorylase inhibitors |
| 12/11/2002 | EP1149104B1 Pyrrolobenzodiazepine carboxyamide vasopressin agonists |
| 12/11/2002 | EP1095025B1 Benzimidazoles, production thereof and use thereof as medicaments |
| 12/11/2002 | EP1071433B1 2',2'-difluoronucleosides for immunosuppressive therapy and combined pharmaceutical compositions |
| 12/11/2002 | EP1056716B1 Cyclohexanediole derivatives |
| 12/11/2002 | EP1051421B1 Compounds containing boron for electron microscopy and for boron neutron-capture therapy |
| 12/11/2002 | EP1023072B1 Analgesic compositions comprising a cholecystokinin and an opioid |
| 12/11/2002 | EP1017378B1 Amide derivatives for the treatment of diseases mediated by cytokines |
| 12/11/2002 | EP0984943B1 Azacyclooctane and heptane derivatives, their preparation and usein therapy |
| 12/11/2002 | EP0981521B1 Novel macrocyclic compounds as metalloprotease inhibitors |
| 12/11/2002 | EP0942741B1 Lectin compositions and uses thereof |
| 12/11/2002 | EP0937064B1 Substituted oximes derivatives useful as neurokinin antagonists |
| 12/11/2002 | EP0925294B1 Substituted 2(2,6-dioxopiperidin-3-yl)phthalimides and -1-oxoisoindolines and method of reducing tnf-alpha levels |
| 12/11/2002 | EP0923568B1 Novel benzofuran-4-carboxamides |
| 12/11/2002 | EP0907632B1 Inhibition of matrix metalloproteases by substituted phenethyl compounds |
| 12/11/2002 | EP0894001B1 Inhibitor of immunoglobulin e antibody production for the treatment of type i allergy-related diseases |
| 12/11/2002 | EP0863891B1 (methylsulfonyl)phenyl-2-(5h)-furanones as cox-2 inhibitors |
| 12/11/2002 | EP0837854B1 Alkyl amine derivatives of substituted quinoxaline 2,3-diones as glutamate receptor antagonists |
| 12/11/2002 | EP0831871B1 Relaxin-like factor and methods and uses thereof |
| 12/11/2002 | EP0820289B1 Trapidil for use in the treatment of immuno-modulatorily influencible cases |
| 12/11/2002 | EP0805796B1 Cell adhesion inhibitors |
| 12/11/2002 | EP0802985B1 Cell cycle regulated repressor and dna element |
| 12/11/2002 | EP0793498B1 Bicyclic heterocyclic compounds for the treatment of impotence |
| 12/11/2002 | EP0754052B1 Antiviral wound healing composition containing a pyruvate, an antioxidant, a mixture of fatty acids and an antiviral compound |
| 12/11/2002 | EP0752813B1 Inhibitors of metazoan parasite proteases |
| 12/11/2002 | EP0721455B1 Tetrahydropyridine-(or 4-hydroxypiperidine)alkylazoles having an affinity for sigma and/or 5ht1a receptors |
| 12/11/2002 | CN1385036A Communications system |
| 12/11/2002 | CN1384878A IREN protein, its preparation and use |
| 12/11/2002 | CN1384835A Tricycle inhibitors of poly(ADP-ribose) polymerases |
| 12/11/2002 | CN1384834A Pyrrolo [2,3-d] pyrimidine nucleoside analoys |
| 12/11/2002 | CN1384833A Synthesis and methods of use of 9-substituted guanine derivatives |
| 12/11/2002 | CN1384829A Sodium-hydrogen exchanger type 1 inhibitor crystals |
| 12/11/2002 | CN1384814A Phenoxy carboxylic acid compounds and compositions for delivering active agents |
| 12/11/2002 | CN1384759A Single-stranded oligodeoxynucleotide mutional vectors |
| 12/11/2002 | CN1384757A Method for down-regulating GDF-8 activity |
| 12/11/2002 | CN1384756A Pharmaceutical formulations and use thereof in prevention of stroke, diabetes and/or congestive heart failure |
| 12/11/2002 | CN1384752A Remedies for nervous diseases |
| 12/11/2002 | CN1384750A Plant extract mixtures and their uses |
| 12/11/2002 | CN1384749A Use of diphophonic acid in treatment of vasculogenesis |
| 12/11/2002 | CN1384746A 单位剂量形式 Unit dosage forms |
| 12/11/2002 | CN1384744A Isoxazole derivatives to be used as phosphodiestesterase VII inhibitors |
| 12/11/2002 | CN1384742A Use of bis-sulfonamides for producing medicaments used for preventing or treating hyperlipidaemia |
| 12/11/2002 | CN1384741A Selective COX-2 inhibitory novel esters from indolealkanols and novel amides from indolealkylamines |
| 12/11/2002 | CN1384738A Transdermal drug delivery devices |
| 12/11/2002 | CN1384713A Dietary food supplement containing natural cyclooxygenase inhibitors |
| 12/11/2002 | CN1384104A Usage, kit and composition of pyrrole derivative |
| 12/11/2002 | CN1384100A Benzo-1,3-dioxole and benzofuran substituted pentazane derivative |
| 12/11/2002 | CN1383887A Antisenility medicine composition and its prepn |
| 12/11/2002 | CN1383870A Fatigue-resisting health food |
| 12/11/2002 | CN1383864A Medicine for strengthning intelligence and delaying senility and its prepn |
| 12/11/2002 | CN1383843A Wild hibiscus holographic-essence |
| 12/11/2002 | CN1383828A Blood-type grasserie preventing and treating medicine for silkworm and its prepn |
| 12/11/2002 | CN1383825A Flunarizine hydrochloride injection and its prepn process |
| 12/11/2002 | CN1383742A Health food of blood fat-regulating and intelligence growth-promoting peptide |
| 12/11/2002 | CN1095839C 4,5-diaryl oxazole derivatives |
| 12/11/2002 | CN1095835C Tricyclo-substituted isohydroxyloxime acid derivative |
| 12/11/2002 | CN1095663C Method for inhibiting LDL oxidation and atherosclerosis |
| 12/11/2002 | CA2411165A1 Novel indole derivatives exhibiting chymase-inhibitory activities and process for preparation thereof |
| 12/10/2002 | USRE37933 Locally administering to mammalian vascular smooth muscle cells replication defective recombinant adenovirus comprising gene encoding mammalian gax protein, wherein gene is expressed and proliferation of cells is inhibited |
| 12/10/2002 | US6492552 Disulfide derivatives useful for treating allergic diseases |
| 12/10/2002 | US6492520 Substituted pyrido-or pyrimido-containing 6,6- or 6,7-bicyclic derivatives |
| 12/10/2002 | US6492516 Pharmaceutically acceptable salts thereof which exhibit utility for the treatment of cytokine mediated diseases such as arthritis. |
| 12/10/2002 | US6492507 Polynucleotides encoding human eosinophil-derived basic protein |
| 12/10/2002 | US6492496 Antibodies to the receptor protein designated 2F1 |
| 12/10/2002 | US6492495 PTP-S31: a novel protein tyrosine phosphatase |
| 12/10/2002 | US6492425 Inhibitors of transcription factor-NF-κB |
| 12/10/2002 | US6492423 Hepatitis c and b viricides |
| 12/10/2002 | US6492422 Tricyclic sulfonamides and their derivatives as inhibitors of matrix metalloproteinases |
| 12/10/2002 | US6492416 4,5-diaryl-3(2H)-furanone derivatives as cyclooxygenase-2 inhibitors |
| 12/10/2002 | US6492412 Prevention of loss and restoration of bone mass by certain prostaglandin agonists |
| 12/10/2002 | US6492409 Such as 5-(1-(3-aminopropyl)-3-indolyl)-1-(3-indolyl)-1,3-dihydroimidazol-2-one; protein kinase c inhibitors; high solubility; reduced color; treating inflammatory and/or immunological disorders |
| 12/10/2002 | US6492408 Peptidomimetic inhibitors of intercellular adhesion molecules binding to leukointegrins, such as lfa-1 and mac-1 |
| 12/10/2002 | US6492402 Anticoagulants; peptide derivatives having high antithrombotic activity and oral bioavailability |
| 12/10/2002 | US6492401 Sodium hydrogen exchanger type 1 inhibitors; reducing perioperative myocardial tissue damage |